Daniela Catarzi - Search Results

Year	Number of Results
2002	1
2003	2
2004	5
2005	4
2006	3
2007	4
2008	4
2009	4
2010	1
2011	2
2012	2
2013	2
2014	3
2015	3
2016	4
2017	5
2018	6
2019	6
2020	5
2021	2
2022	4
2023	2
2024	0

1

CK1 delta inhibition: an emerging strategy to combat neurodegenerative diseases.

Varano F, Catarzi D, Calenda S, Vigiani E, Colotta V. Varano F, et al. Among authors: catarzi d. Future Med Chem. 2022 Aug;14(15):1111-1113. doi: 10.4155/fmc-2022-0129. Epub 2022 Jul 8. Future Med Chem. 2022. PMID: 35801420 No abstract available.

2

A_2A Adenosine Receptor Antagonists and their Potential in Neurological Disorders.

Lambertucci C, Marucci G, Catarzi D, Colotta V, Francucci B, Spinaci A, Varano F, Volpini R. Lambertucci C, et al. Among authors: catarzi d. Curr Med Chem. 2022 Aug 6;29(28):4780-4795. doi: 10.2174/0929867329666220218094501. Curr Med Chem. 2022. PMID: 35184706 Review.

3

Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders.

Catarzi D, Varano F, Vigiani E, Lambertucci C, Spinaci A, Volpini R, Colotta V. Catarzi D, et al. Curr Med Chem. 2022;29(27):4698-4737. doi: 10.2174/0929867329666220301115124. Curr Med Chem. 2022. PMID: 35232339 Review.

4

Competitive AMPA receptor antagonists.

Catarzi D, Colotta V, Varano F. Catarzi D, et al. Med Res Rev. 2007 Mar;27(2):239-78. doi: 10.1002/med.20084. Med Res Rev. 2007. PMID: 16892196 Review.

5

Special Issue "Adenosine Receptors as Attractive Targets in Human Diseases".

Catarzi D, Varano F, Colotta V. Catarzi D, et al. Pharmaceuticals (Basel). 2021 Feb 10;14(2):140. doi: 10.3390/ph14020140. Pharmaceuticals (Basel). 2021. PMID: 33578687 Free PMC article.

6

Competitive Gly/NMDA receptor antagonists.

Catarzi D, Colotta V, Varano F. Catarzi D, et al. Curr Top Med Chem. 2006;6(8):809-21. doi: 10.2174/156802606777057544. Curr Top Med Chem. 2006. PMID: 16719819 Review.

7

Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazoline-2-carboxylates as novel excitatory amino acid antagonists.

Varano F, Catarzi D, Colotta V, Filacchioni G, Galli A, Costagli C, Carlà V. Varano F, et al. Among authors: catarzi d. J Med Chem. 2002 Feb 28;45(5):1035-44. doi: 10.1021/jm010995b. J Med Chem. 2002. PMID: 11855983

8

Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4- oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists.

Catarzi D, Colotta V, Varano F, Calabri FR, Filacchioni G, Galli A, Costagli C, Carlà V. Catarzi D, et al. J Med Chem. 2004 Jan 1;47(1):262-72. doi: 10.1021/jm030906q. J Med Chem. 2004. PMID: 14695840

9

Development of novel pyridazinone-based adenosine receptor ligands.

Catarzi D, Varano F, Falsini M, Varani K, Vincenzi F, Pasquini S, Dal Ben D, Colotta V. Catarzi D, et al. Bioorg Med Chem Lett. 2018 May 15;28(9):1484-1489. doi: 10.1016/j.bmcl.2018.03.086. Epub 2018 Mar 30. Bioorg Med Chem Lett. 2018. PMID: 29627261

10

4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives.

Catarzi D, Varano F, Vigiani E, Calenda S, Melani F, Varani K, Vincenzi F, Pasquini S, Mennini N, Nerli G, Dal Ben D, Volpini R, Colotta V. Catarzi D, et al. Pharmaceuticals (Basel). 2022 Apr 14;15(4):478. doi: 10.3390/ph15040478. Pharmaceuticals (Basel). 2022. PMID: 35455475 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

67 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year